Triamterene (triamterene capsules) NDC 52817-364

NDC codes

FDA NDC Directory

Product NDC (as listed)52817-364Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52817-0364Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52817-364-10	52817036410	100 CAPSULE in 1 BOTTLE (52817-364-10)Marketed from Dec 12, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamterene
Generic name (nonproprietary): triamterene capsules
Active ingredients: Triamterene — 50 mg/1
Dosage form: Capsule
Route: Oral
Labeler: TRUPHARMA LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211581
Marketing start: Dec 12, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Renal K+ Excretion (Physiologic effect)Increased Diuresis (Physiologic effect)
Identifiers: Product ID 52817-364_79343fce-fab3-4847-9bd2-09ae1b363827SPL ID 79343fce-fab3-4847-9bd2-09ae1b363827SPL set ID fea50328-b3d5-4300-8c67-82cda0a975b7RxCUI 198312, 198313UNII WS821Z52LQUPC 0352817364104
Pharmacologic class: Potassium-sparing Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452817036410 followed by a unit qualifier and the quantity

Package 52817-0364-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 1, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE Triamterene Capsules USP is indicated in the treatment of edema associated with congestive heart failure, cirrhosis of the liver and the nephrotic syndrome; steroid-induced edema, idiopathic edema and edema due to secondary hyperaldosteronism. Triamterene Capsules USP may be used alone or with other diuretics, either for its added diuretic effect or its potassium-sparing potential. It also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism. Usage in Pregnancy. The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211581

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211581
Product	Strength	Form · route	Labeler	Product NDC
Triamterenetriamterene capsules	Triamterene 50 mg/1	CapsuleOral	Bryant Ranch Prepack	72162-2265
Triamterenetriamterene capsules	Triamterene 100 mg/1	CapsuleOral	TRUPHARMA LLC	52817-365